Categories
Pharmaceutical

Endoscopy Ultrasound Market is projected to expand substantially at a CAGR of 5.7% during the forecast period 2021-2026

The scope of global endoscopy ultrasound market has widened since the past few years. This is primarily attributed to the increased incidences of gastrointestinal cancers across the world. The World Health Organization (WHO) estimates that more than 700,000 cancer-related casualties are a result of stomach cancers. Therefore, adoption of endoscopy ultrasound procedures has become important. Owing to the current COVID-19 pandemic, healthcare workers are delaying elective endoscopic ultrasound procedures to reduce transmission from infected patients to healthcare workers. This is anticipated to moderately impact the market in the near term

On the back of these trends, the global endoscopy ultrasound market is poised to experience a positive growth path, expanding 1.5x during the forecast period (2020-2026). The affordability of endoscopy ultrasound procedures in terms of money as compared to procedures such as Endoscopic Retrograde Cholangiopancreatography (ERCP) shall also augment market growth.

Request a report sample to gain comprehensive insights at https://www.factmr.com/connectus/sample?flag=S&rep_id=4689

endoscopy ultrasound market 01

Key Takeaways of Global Endoscopy Ultrasound Market Study:

  • By product type, the endoscopes segment is anticipated to capture a considerable portion of the global endoscopy ultrasound market. Projections indicate a market share greater than one-third. Important innovations such as installation of transducers and cameras are poised to uplift market prospects.
  • However, the needles segment is poised to expand rapidly, growing 1.5x and capturing almost a quarter of the endoscopy ultrasound market. Their low cost, single-use feature and application in aspiration and biopsy procedures are key growth determinants for the segment.
  • By application, the oncology segment shall capture the majority of the global endoscopy market, amounting to more than 3/4th. Increased applicability in detecting and treatment of gastrointestinal cancers, introduction of new techniques such as elastography and contrast-enhanced endoscopy ultrasound (CE-EUS) are important growth levers.
  • In terms of procedure, the upper EUS segment is anticipated to account for more than 70% of the global endoscopy ultrasound market. Preference for endoscopy ultrasound in diagnostic and therapeutic applications of upper gastrointestinal cancer is augmenting the segment’s growth.
  • By technology, linear scanning is anticipated to be very lucrative, owing to its suitability in performing therapeutic procedures for various GI cancers and pancreatic conditions. Anticipated CAGR for the linear scanning segment is pegged at 5.8% during the forecast period.
  • By region, North America shall dominate the global endoscopy ultrasound market, growing at a CAGR of 5.8% and capturing more than 2/5th of the market. This is because of rising demand for more advanced diagnostic procedures to address GI cancers.
  • Asia-Pacific shows burgeoning market prospects. This is supported by an increasing patient pool suffering from gastrointestinal and pancreatic cancers as well as higher penetration of EUS techniques in hospital and other healthcare settings. The region is anticipated to expand nearly 2.0x, capturing around 2/5th of the global endoscopy ultrasound market.
  • The COVID-19 pandemic is anticipated to register a marginal decline in the production of endoscopy devices for elective purposes. Key market players such as FUJIFILM have redirected their resources in drug development. FUJIFILM has initiated the third phase of its clinical trial for Avigan anti-influenza drug. The drug specifically inhibits RNA polymerase associated with influenza virus replication.
  • Companies such as Olympus Corporation have encouraged work from home and restricted international travel of all its employees. The company claims that its operations shall run on a regular basis as certain departments work on a shift-basis.

Request More Information about Report Methodology
https://www.factmr.com/connectus/sample?flag=RM&rep_id=4689

“The global endoscopy ultrasound market shows positive growth trends. Rising prevalence of gastrointestinal and pancreatic cancers are anticipated to drive the market growth. Key market players are thus concentrating on technological breakthroughs in order to provide better quality products and solutions,” concludes a Fact.MR analyst.

Global Endoscopy Ultrasound Market: Competitive Landscape:

The global endoscopy ultrasound market is dominated by three market players: are Olympus Corporation, PENTAX Medical (HOYA Corporation) and FUJIFILM Corporation. These companies are constantly innovating their technologies to provide quality solutions to their clients.

For instance, Olympus Corporation is the leading player. It focuses on strong organic growth through new and innovative product introductions. For example, in 2016, the company announced the launch of its EZ Shot 3 Plus single-use aspiration needle for endoscopic ultrasound-fine needle aspiration (EUS-FNA) procedures. Currently, it manufactures the ProSound F75 Endoscopy Ultrasound Processor and the EU-ME2 High Quality Ultrasound Processor.

Get More Insights-https://www.biospace.com/article/global-endoscopy-ultrasound-market-is-projected-to-expand-substantially-at-a-cagr-of-5-7-percent-by-2026/

Similarly, FUJIFILM Corporation launched its Vevo MD, an ultra-high frequency (UHF) clinical ultrasound system in 2016 after receiving clearance from the U.S. Food and Drug Administration (FDA). Its other imaging solutions include the EG-530 UR Ultrasound Video Bronchoscope and the EG-530 UT Ultrasonic Processor SP-900.

Explore Fact.MR’s Coverage on the Healthcare Domain

Radiation proctitis treatment market: A recent study by Fact.MR on the radiation proctitis treatment market offers a 10-year forecast analysis for the period 2018 to 2028. The study analyzes key trends that are currently determining the growth of the market. This report covers key dynamics, including drivers, restraints, and opportunities for leading market players along with key stakeholders and emerging players.

Radiation Nephropathy Treatment and Management Market: Fact. MR’s extensive coverage on the radiation nephropathy treatment and management market offers in-depth insights about the prominent growth dynamics that are likely to aid expansion of growth prospects in the near future. Data has been presented in the form of key segments across prominent geographies, along with important information concerning key manufacturers operating within the industry.

Cancer therapeutics market: The global cancer therapeutics market study published by Fact.MR offers an unbiased analysis of the prominent drivers, opportunities and trends expected to shape future expansion outlook. The report provides a comprehensive assessment on the prominent segments and geographies which are likely to benefit market players in forthcoming years.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Research Insight: https://www.factmr.com/report/4689/endoscopy-ultrasound-market
Press Release: https://www.factmr.com/media-release/1440/global-endoscopy-ultrasound-market
Follow Us: LinkedIn | Twitter

Categories
Pharmaceutical

Dental Endodontics Market is projected to reach a valuation of US$ 1.8 Bn by 2025- Exclusive Report by Fact.MR

Influence of dental tourism to avail affordable, yet quality dental care, in tandem with rising consciousness regarding oral health and hygiene, signifies promising opportunities for players in the dental endodontics market.

A recent study by Fact.MR further analyses the dental endodontics market in detail, and finds that endodontic motor instruments continue to hold a sizeable market share, given their competency to offer time-efficient root canal procedures that help dentists in achieving high productivity. Market players are moving towards nickel and titanium materials to provide high elasticity to endodontic instruments, thereby complementing the adoption rate.

Request a report sample to gain comprehensive insights at https://www.factmr.com/connectus/sample?flag=S&rep_id=4436

Despite being conventional, consumables are evolving with advanced technology, and market players are experimenting with various parameters such as design and material to increase convenience for dentists. On the back of growing preference for quicker, safer, and reliable systems, adoption of dental endodontics instruments is projected to remain significantly higher than consumables during the forecast period.

opportunity analysis of dental endodontics market by end users

Key Highlights of Dental Endodontics Market Study

  • A marked shift from 2D imaging systems to 3D cone beam imaging technology, which is gradually transforming the way dentists collect information, serves as a harbinger of significant adoption opportunities for players in the dental endodontics market.
  • Accuracy and versatility are viable propositions to achieve marketing success; however, the emergence of laser dentistry as an effective substitute for dental endodontics could challenge the otherwise steady adoption rate of endodontic systems.
  • Dental clinics would retain their status as primary dental care centres, as short-wait times and cost-effective solutions remain key touchpoints for individuals. On the back of this influential growth enabler, demand for dental endodontics from dental clinics is likely to remain 32% higher than dental hospitals.
  • Density of the geriatric population is significantly high in Japan, which generates high demand for dentistry in the country. Also, technological advancements come to the disposal of players operating in the dental endodontics market. During the forecast period, Japan is likely to register the highest CAGR of around 6.3%.

Request More Information about Report Methodology
https://www.factmr.com/connectus/sample?flag=RM&rep_id=4436

A subject matter expert portends,

“Strong revenue opportunity would open for manufacturers in the dental endodontics market, as dental academic and research institutes are adopting dental endodontic systems to foster innovation and advancement. Intense research undertaken by these institutes is leading to cost-effective development of these systems.”

Strategic Acquisitions to Remain at Leading Players’ Disposal

Strong geographical presence, strategic acquisitions, and collaborations are key strategies undertaken by players in the dental endodontics market to strengthen their market position. For instance, in 2017 COLTENE Holding AG announced the acquisition of Micro-Mega and SciCan, which are key companies working towards the development of dental equipment and materials, by investing around US$ 200 Mn. In addition, in September 2017, Dentsply Sirona announced the acquisition of Healthdent Technologies Inc. to boast a diversified range of root canal treatment solutions.

Prominent as well as emerging players in the dental endodontics market, however, evince high reliance on product innovation and effective marketing strategies to distinguish their brands and increase brand value.

Get More Insights- https://www.accesswire.com/619958/Rising-Demand-for-Dental-Endodontics-from-Dental-Clinics-to-Remain-Significant-Growth-Enabler-FactMR

Find More Valuable Insights on Dental Endodontics Market

Fact.MR, in its new offering, brings to the fore an unbiased analysis of the global dental endodontics market, presenting historical demand data (2015-2019), and forecast statistics for the period of 2020-2025. The study divulges compelling insights on the dental endodontics market on the basis of product (instruments and consumables), and end user (dental hospitals, dental clinics, dental academic and research institutes, and others), across five major regions.

Explore Fact.MR’s Coverage on the Healthcare Domain

Radiation proctitis treatment market: A recent study by Fact.MR on the radiation proctitis treatment market offers a 10-year forecast analysis for the period 2018 to 2028. The study analyzes key trends that are currently determining the growth of the market. This report covers key dynamics, including drivers, restraints, and opportunities for leading market players along with key stakeholders and emerging players.

Radiation Nephropathy Treatment and Management Market: Fact. MR’s extensive coverage on the radiation nephropathy treatment and management market offers in-depth insights about the prominent growth dynamics that are likely to aid expansion of growth prospects in the near future. Data has been presented in the form of key segments across prominent geographies, along with important information concerning key manufacturers operating within the industry.

Cancer therapeutics market: The global cancer therapeutics market study published by Fact.MR offers an unbiased analysis of the prominent drivers, opportunities and trends expected to shape future expansion outlook. The report provides a comprehensive assessment on the prominent segments and geographies which are likely to benefit market players in forthcoming years.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Research Insight: https://www.factmr.com/report/4436/dental-endodontics-market
Press Release: https://www.factmr.com/media-release/1218/dental-endodontics-demand
Follow Us: LinkedIn | Twitter

Categories
Pharmaceutical

Optometry Equipment Market is expected to gain US$ 2 Billion worth incremental opportunity by 2029

Estimated to witness ~4% Y-o-Y growth in the revenues over 2018, the global optometry equipment market is likely to reach ~US$ 4 Bn in 2019. Fact.MR’s latest market intelligence on optometry equipment suggests that ~37% of overall sales are accounted by ophthalmic diagnostic equipment, which points to the soaring significance of diagnostics in the eye car industry. The report also points to the promising progress in the revenue shares of surgery devices in optometry equipment market.

The global optometry equipment market is expected to experience promising growth over the forecast period. The report attributes this growth outlook to an increase in the geriatric population and the subsequent rise in prevalence of Asthenopia (eye strain). Vision loss has been among the most widespread conditions worldwide, particularly in aging population that is more prone to diabetes. This, according to Fact.MR’s research, is accounting for complications in procedures, such as retinopathy leading to vision impairment, which is another factor fueling the growth of optometry equipment market.

Request a report sample to gain comprehensive insights at https://www.factmr.com/connectus/sample?flag=S&rep_id=363

While an increasing number of cataract and glaucoma cases continues to underscore the criticality of pushing the accessibility and affordability of eye care, the report finds that a growing number of multi-specialty clinics, hospital OPDs, and dedicated eye care centers will be a prominent booster. Improving coverage for vision care, particularly in developing economies, is contributing to the efforts in increasing affordability of ophthalmic care, which remains a strong factor boosting sales of optometry equipment over the forthcoming years.

global optometry equipment market snapshot

North America & Europe Collectively Account for ~60% Sales

Technological advancements in optometry equipment have significantly reduced the cost of treatment, which can be attributed to improvements in processes, efficiency, and efficacy of optometry equipment. North America continues to reap the first-mover advantage, as technology remains the cornerstone of steadily expanding optometry equipment landscape. The region, owing to strong presence of practicing ophthalmologists and favorable reimbursement scenario, remains the prime market for the stakeholders in optometry equipment market.

The study opines that Europe is also a developing a lucrative investment pocket for participants, banking on rapidly soaring sales of diagnostic and screening equipment. Fact.MR’s analysis indicates that North America and Europe currently contribute a collective share of ~3/5th of total market revenues.

Request More Information about Report Methodology
https://www.factmr.com/connectus/sample?flag=RM&rep_id=363

An increasing number of optometry equipment clinics & hospitals are being set up across various countries across the globe to meet the needs of the increasing number of patients suffering from eye problems, which is boosting the demand for optometry equipment for onsite installation. For instance, in 2013–2014, the number of hospital visits by patients has increased significantly in the U.K., which has crossed over 100 million outpatient appointments. Of these, 10% were only for eye care, thus boosting the usage and demand of optometry equipment.

The optometry equipment market landscape comprises a select set of national/regional chains and over 10,000 independent providers. Small industry players, which include local manufacturers operating in the optometry equipment market, are looking to expand their network and broaden their reach to patients and referral networks. There has been thus a considerable increase in the number of strategic mergers and acquisitions in the optometry equipment market landscape, over the recent past.

Get More Insights- https://www.biospace.com/article/optometry-equipment-market-surging-at-4-percent-cagr-driven-by-increasing-prevalence-of-ophthalmic-disorders-fact-mr-study/

This Fact.MR study tracks the growth of optometry equipment market between 2019 and 2029. The report has projected a steady ~4% CAGR for the market revenues through 2029.

Explore Fact.MR’s Coverage on the Healthcare Domain

Radiation proctitis treatment market: A recent study by Fact.MR on the radiation proctitis treatment market offers a 10-year forecast analysis for the period 2018 to 2028. The study analyzes key trends that are currently determining the growth of the market. This report covers key dynamics, including drivers, restraints, and opportunities for leading market players along with key stakeholders and emerging players.

Radiation Nephropathy Treatment and Management Market: Fact. MR’s extensive coverage on the radiation nephropathy treatment and management market offers in-depth insights about the prominent growth dynamics that are likely to aid expansion of growth prospects in the near future. Data has been presented in the form of key segments across prominent geographies, along with important information concerning key manufacturers operating within the industry.

Cancer therapeutics market: The global cancer therapeutics market study published by Fact.MR offers an unbiased analysis of the prominent drivers, opportunities and trends expected to shape future expansion outlook. The report provides a comprehensive assessment on the prominent segments and geographies which are likely to benefit market players in forthcoming years.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Research Insight: https://www.factmr.com/report/363/optometry-equipment-market
Press Release: https://www.factmr.com/media-release/352/optometry-equipment-market
Follow Us: LinkedIn | Twitter

Categories
Pharmaceutical

Bacteriophage Market projected to expand at a CAGR of over 4% throughout the forecast period of 2021-2030

Award winning market research company Fact.MR has published the global bacteriophage market research report. According to the study, the market exhibits high growth potential, expected to yield credible gains through 2021. Long-term prospects also appear positive, with a predicted CAGR exceeding 4% through 2031.

The market was valued at approximately US$ 39 million in 2019, with surging applications in gastroenterology underpinning growth. A study conducted by the University of Gothenburg has established that nearly 40% of adults suffer from at least one functional gastrointestinal disorder, with disorders such as inflammatory bowel diseases being highly prevalent. Excessive reliance on antibiotics has led to a surge in antimicrobial resistance, causing numerous GI problems.

Request a report sample with 170 pages to gain comprehensive insights at https://www.factmr.com/connectus/sample?flag=S&rep_id=5558

According to the World Health Organization, the rate of resistance such as ciprofloxacin ranges between 8.4% and 92.9% for E. coli, and from 4.1% to 79.4% for K. Pneumoniae. Hence, the medical fraternity is investigating alternative treatment approaches, leading to heightened prospects for bacteriophage based supplements. Manufacturers are augmenting their research capacities, increasing the frequency of clinical trials and funding studies by establishing international level coalitions.

“Growing emphasis on maintaining gut microbiome health is prompting increased consumption of bacteriophage infused supplements and medicines. Recent government legislations such as the emergency investigational new drug (eIND) pathway by the US FDA have enabled healthcare settings to incorporate bacteriophage products in their diagnostics and treatment procedures,” remarks a Fact.MR analyst.

bacteriophage market application

Key Takeaways from Fact.MR’s Bacteriophage Market Study

  • By product, phage probiotics to enjoy an elevated market share, capturing over 9 out of 10 sales in 2021
  • Gastroenterology to remain key bacteriophage therapeutics application area, owing to surging digestive tract disorders
  • Oral bacteriophage products administration to remain highly preferred through 2021
  • By distribution channel, retail and hospital pharmacies to emerge as the primary bacteriophage selling points
  • US to experience high growth in bacteriophage sales, amid recent FDA approvals for the oral ingestion of bacteriophage cocktails in dietary supplements
  • Increasing frequency of inhaled phage therapy to heighten growth prospects across the UK
  • India, Russia & Georgia to emerge as lucrative bacteriophage markets amid accelerating research and development for determining efficacy of such products

Bacteriophage Market- Prominent Drivers

  • The global bacteriophage market is driven by unceasing research & development activities for discovering novel treatment approaches
  • Growing burden of antibiotic resistance is prompting patients to opt for safer alternatives, accelerating growth prospects
  • Increasing global level coalitions amongst prominent manufacturers to accelerate bacteriophage development to stimulate further growth

Bacteriophage Market- Key Restraints

  • Non-approval for human consumption by regulatory authorities due to perceived lacunae in effectiveness to restrain growth
  • Uncertainties regarding potential mutations of bacteria strains leading to phage resistance development to limit commercial availability

Get More Insights- https://www.accesswire.com/630981/Bacteriophage-Probiotics-to-generate-over-9-out-10-Sales-Attributed-to-Surging-Antibiotic-Resistance-FactMR

Competitive Landscape

Life Extension, Arthur Andrew Medical, Deerland Probiotics & Enzymes Inc., BioChimPharm, Micreos Human Health, Designs for Health, Accelerated Health Systems Inc., The Biostation, Probiotic America and Microgen are some prominent bacteriophage manufacturers included in Fact.MR’s report. Development of novel phase therapies to cater to specific healthcare requirements.

Life Extension, for instance, manufactures the FLORASSIST® GI probiotic formula for ensuring the best digestive probiotic benefits. Being gluten free, non-GMO and vegetarian, the formula targets unwanted bacteria with a novel bacteriophage blend with various healthy probiotic strains.

Looking for Specific Region & Segment Analysis? Request Report Customization https://www.factmr.com/connectus/sample?flag=RC&rep_id=5558

In 2019, BioChimPharm received a grant from the Georgian Innovation and Technology Agency for its PowerPhage veterinary antimicrobial. The product is highly effective in fighting harmful bacteria such as Salmonella, E. coli and Shigella, eliminating them without harming the beneficial microflora of the organism.

Key Questions Answered in the Report

  • How is the bacteriophage market expected to assume shape in 2021?
  • Why is Russia expected to emerge as a lucrative bacteriophage market?
  • What drivers are expected to underpin future market outlook?
  • Which restraints are expected to hamper the bacteriophages market growth?
  • How are regulatory frameworks expected to influence market growth?
  • Which are the prominent bacteriophage market players?

Request More Information about Report Methodology

https://www.factmr.com/connectus/sample?flag=RM&rep_id=5558

Strategic Partnerships and Funding by Manufacturers for Development of Phage Therapeutics

Pharmaceutical companies are collaborating with a collective goal to foster innovation by working with biotech firms and companies, governments, and market stakeholders, to enable supportable investments into a novel pipeline of bacteriophage therapy.

For instance, Janssen Pharmaceuticals, Inc. and Locus Biosciences Inc., in 2019, signed a complete license and collaboration agreement to manufacture, develop, and commercialize CRISPR-Cas3-enhanced bacteriophage (crPhage) products for the treatment of various infections, such as respiratory tract infection caused by two key pathogens, and other related infections. For this, Locus will receive US$ 20 million as an initial payment, which is expected to reach US$ 798 million from future sales of the product.

Such partnerships between pharmaceutical companies are aimed at strengthening and accelerating phage therapy development to introduce new therapies by end of this decade.

Explore Fact.MR’s Coverage on the Healthcare Domain

Medical Ceramics Market: A recent study by Fact.MR on the medical ceramics market offers a 10-year forecast from 2021 to 2031. The study analyzes crucial trends that are currently determining market growth. This report explicates on vital dynamics, such as the drivers, restraints, and opportunities for key market players along with key stakeholders and emerging players.

Indirect Calorimeter Market: A detailed assessment of the indirect calorimeter value chain analysis, business execution, and supply chain analysis across regional markets has been covered in Fact.MR’s extensive coverage on the subject. The study incorporates a detailed assessment of the market drivers, opportunities and trends influencing future expansion trajectory over key geographies and segments for the upcoming decade.

Viral Antigens Market: Fact.MR’s incisive coverage on the global viral antigens market provides a holistic view of the prominent expansion dynamics expected to shape future growth prospects. The report covers a detailed analysis of the prominent trends prevailing across key geographies and prominent segments for the next decade.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Research Insight: https://www.factmr.com/report/bacteriophage-market
Press Release: https://www.factmr.com/media-release/1836/global-bacteriophage-market
Follow Us: LinkedIn | Twitter

Categories
Pharmaceutical

Targeted Therapy Drugs Expand the Bandwidth of Injectable Oncology Small Molecule Drugs Industry Finds Fact.MR

According to a recent study by Fact.MR, sales of oncology small molecule drugs are envisaged to surpass US$ ~66 Bn in 2019, up from revenues worth US$~63 Bn attained in 2018.

Gains are prominently underpinned by spectacular rise in cancer prevalence, rapid proliferation of oncology centers, and improving availability of oral small molecule drugs for cancer treatment.  The report suggests that a number of oncology small molecule drugs are getting approvals, which are potentially effective in treating unresectable cancers, which clearly points to a positive growth outlook for the oncology small molecule drugs market.

The oncology small molecule drugs market is growing in parallel with the increasing collaborative efforts and initiatives of biopharma companies, investing in early cancer diagnosis and therapeutics. Increasing number of pipeline studies and rising R&D funding for healthcare industry will continue to create fresh growth avenues in the form of NPDs, thereby driving the growth of oncology small molecule drugs market.

Click Here To get a Sample Report (Including Full TOC, Table & Figures) https://www.factmr.com/connectus/sample?flag=S&rep_id=3747

50% of Sales Remain Concentrated in North America

According to the Fact.MR study, sales of oncology small molecule drugs will remain concentrated in North America, primarily driven by the high prevalence of cancers and advanced treatment infrastructure in the region. Increasing funds from governments as well as private organizations for the development of advanced and improved cancer treatments, will remain the key growth influencers associated with the growth of oncology small molecule drugs market in North America.

In 2018, North America accounted for half the sales of oncology small molecule drugs, and will continue to remain the most lucrative market for stakeholders. Stringent approval regulations, especially in developing countries, such as Japan, will continue to limit the penetration of oncology small molecule drugs in these regions to an extent. Furthermore, Japan, peculiarly having one of the most difficult approval processes for new drug molecules, holds an impressive opportunistic potential for market leaders that are striving for quicker drug approvals by improving R&D processes and expansion strategies, targeting developing countries.

The study opines that advanced and orally viable cancer drugs are adding value to the attractive market potential of oncology small molecule drugs, among an ever-growing pool of patients. Broader factors concerning cancer treatment, especially the unavailability of proper drugs in several regions and laser-sharp focus on increasing drug absorption in cells by leveraging small molecule drugs, are likely to shape revenue generation in the oncology small molecule drugs market.

Connect To an Expert https://www.factmr.com/connectus/sample?flag=AE&rep_id=3747

oncology small molecule drugs market taxonomy

Key Prominent Players

  • Novartis AG
  • Sanofi S.A.
  • AbbVie Inc.
  • AstraZeneca plc
  • Eli Lilly and Company
  • Bristol-Myers Squibb Company
  • AstraZeneca plc.

The research report published by Fact.MR on the Oncology Small Molecule Drugs Market provides a detailed overview of the demands and consumptions of various products/services associated with the growth dynamics of the market during the forecast period. The in-depth market estimation of various opportunities in the segments is expressed in volumes and revenues. The insights and analytics on the Oncology Small Molecule Drugs Market span several pages. These are covered in numerous sections, including, drivers and restraints, challenges and opportunities, regional segmentation and opportunity assessment, end-use/application prospects analysis, and competitive landscape assessment.

 

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Brazil, Mexico, Argentina, Chile, Peru, Rest of LATAM)
  • EU – (Germany, France, Italy, Spain), UK, BENELUX (Belgium, Netherlands, Luxemburg), NORDIC (Norway, Denmark, Iceland, Sweden), Eastern Europe (Poland, Ukraine, Czech Rep. etc.), Rest of Europe
  • CIS & Russia
  • Japan
  • Asia Pacific Excluding Japan (Greater China, India, S. Korea, ASEAN Countries, Rest of APEJ)
  • Middle East and Africa (GCC Countries, Turkey, Iran, Israel, South Africa, Rest of MEA)

Read More Trending Reports of Fact.MR: – https://www.prnewswire.com/news-releases/home-diagnostics-market-witnessing-heightened-start-up-investments-offering-specialized-solutions-factmr-301212625.html

The Report Covers Exhaustive Analysis On:

  • Market Segments
  • Market Dynamics
  • Market Size & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

The Oncology Small Molecule Drugs Market report offers detailed assessments and quantitative evaluations that shed light on numerous key aspects that have shaped its evolution over the historical period. In coming years, some of the key aspects that will shape the growth prospects during the forecast period are objectively covered in the study.

To Get All-In Insights On the Regional Landscape of The Report Market, Buy Now

https://www.factmr.com/checkout/3747

The research attempts to answer many queries such as:

  1. What needs are the leading manufacturers trying to meet by the forecast period 2025?
  2. What challenges will vendors running the Oncology Small Molecule Drugs Market go through?
  3. What aspects do the consumers look up while buying Oncology Small Molecule Drugs?
  4. How will the competitive framework look like between the foreseeable period 2018 to 2025?
  5. At present, who is buying your product or service globally?
  6. Who are your primary contenders?
  7. What will be the cost of the products and facilities across various regions?
  8. What are the trends affecting the performance of the Oncology Small Molecule Drugs Market?

Need More Information about Report Methodology? Click here

https://www.factmr.com/connectus/sample?flag=RM&rep_id=3747

Benefits of Fact.MR Study

Fact.MR has gradually established itself as one of the leading market research companies across the globe. Our unique, methodical, and up-to-date approach towards creating high-quality market reports ensures the reports include relevant market insights. Further, our team of analysts leaves no stone unturned while curating market reports in accord with the requirement of our clients.

Explore Fact.MR’s Comprehensive Coverage on Healthcare Landscape

Nano Healthcare Technology Market Forecast, Trend, Analysis & Competition Tracking – Global Market Insights 2020 to 2030

Medical Suction Devices Market Forecast, Trend, Analysis & Competition Tracking – Global Market Insights 2020 to 2030

Medical Grade Silicone Market Forecast, Trend, Analysis & Competition Tracking – Global Market Insights 2020 to 2030

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Reach out to us with your goals, and we’ll be an able research partner.

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Revenues from PSA Prostate Cancer Diagnostic Tests Is Projected to Register the Highest CAGR in the Market through 2031

Impact of Covid-19 on Healthcare Industry

With the pandemic plaguing maximum countries across the globe, healthcare industry is witnessing its fair share of ‘ups and downs’. The COVID-19 has placed an enormous strain on the healthcare sector’s workforce, facilities and infrastructure. Despite the endless pressure, healthcare sector is growing at a moderate pace due to the improvement in infrastructure and advancement in technology, healthcare sector is delivering a healthy performance.

According to the latest report by Fact.MR, the global demand for prostate cancer diagnostics is anticipated to exhibit a steady expansion at 5.3% CAGR during the forecast period 2017 to 2022. In terms of revenues, the market is projected to reach US$ 823.5 Mn in 2017; by 2022 this number is projected to surpass US$ 1,000 Mn.

Diagnosis of prostate cancer is becoming a critical undertaking for medical organizations. Newer treatments on prostate cancer are being developed by considering the scope of diagnostic approach. This emergence of diagnosis-associated treatments on prostate cancer is expected to render higher medical efficiency, providing effective outputs at minimal healthcare spending.

For More Insights Into The Market, Request a Sample of this Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=58

Through and through, medical organizations are scanning key criteria associated with diagnosis of prostate cancer, tracking parameters such as age of the patient, ethnicity, family medical history, and diet. Considering the sensitivity of organs in the prostate area, patients are also adopting non-invasive diagnosis tests, which is ultimately impacting the products sold in the global market for prostate cancer diagnostics.

Key players in the global market for prostate cancer diagnostics include

Abbott Laboratories
Biocept, Inc.
AstraZeneca plc.
Cancer Genetics, Inc.
Danaher Corporation
Bayer Aktiengesellschaft
Becton
Dickinson and Company
Agilent Technologies
Foundation Medicine, Inc.
Myriad Genetics Inc.

Global Prostate Cancer Diagnostics Market: Segmentation

For clearer understanding of the Prostate Cancer Diagnostics Market, analysts have segmented the market. The segmentation has been done on the basis of application, technology, and users. Each segment has been further explained with the help of graphs figures. This breakdown of the market gives the readers an objective view of the global Prostate Cancer Diagnostics Market, which is essential to make sound investments.

A market research study is incomplete without regional analysis, and we are well aware of it. That is why, the report includes a comprehensive and all-inclusive study that solely concentrates on the geographical growth of the global Prostate Cancer Diagnostics Market.

Share Your Requirements & Get Customized Reports – https://www.factmr.com/connectus/sample?flag=RC&rep_id=58

5 Estimations from Fact.MR’s Report on the Global Prostate Cancer Diagnostics Market

  1. North America will continue to be the most lucrative region in the global prostate cancer diagnostics market, in terms of revenues. The prostate cancer diagnostics market in North America and Europe are expected to exhibit similar CAGRs through 2022.
  2. The market in Asia-Pacific excluding Japan (APEJ) is expected to register the fastest expansion through 2022. In contrast, prostate cancer diagnostics market in Middle East & Africa will continue to register a sluggish expansion during the forecast period.
  3. PSA tests will continue to be the largest adopted tests for diagnosis of prostate cancer across the globe. PSA test segment is projected to register the highest CAGR in the market through 2022.
  4. Hospital-associated labs are expected to remain the largest end-users of prostate cancer diagnostics in the global market, however revenues from prostate cancer diagnostics in hospital-associated labs will register the lowest CAGR in the market through 2022.
  5. In terms of revenues, cancer research institutes are expected to register the highest CAGR in the market through 2022. Independent diagnostics labs will remain the second largest end users of the prostate cancer diagnostics during the forecast period.

The study also includes accurate estimations about market growth at the global, regional, and country levels. It empowers you to understand why some regional markets are flourishing while others are seeing a decline in growth. It also allows you to focus on geographies that hold the potential to create lucrative prospects in the near future.

By Test Type

  • PSA Tests
  • CTC Tests
  • Immunohistochemistry
  • PCA3 test

By End User

  • Hospital Associated Labs
  • Independent Diagnostic Laboratories
  • Cancer Research Institutes

Following Questions Answers Covered in the Report are:

  • How will the global Prostate Cancer Diagnostics Market perform during the forecast period? What will be the market size in terms of value and volume?
  • Which segment will drive the global Prostate Cancer Diagnostics Market? Which regional market will show extensive growth in the future? What are the reasons?
  • How will the market dynamics change because of the impact of future market opportunities, restraints, and drivers?
  • What are the key strategies adopted by players to sustain themselves in the global Prostate Cancer Diagnostics Market?
  • How will these strategies influence the market growth and competition?

Access Research Methodology Prepared By Experts – https://www.factmr.com/connectus/sample?flag=RM&rep_id=58

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Brazil, Mexico, Argentina, Chile, Peru, Rest of LATAM)
  • EU – (Germany, France, Italy, Spain), UK, BENELUX (Belgium, Netherlands, Luxemburg), NORDIC (Norway, Denmark, Iceland, Sweden), Eastern Europe (Poland, Ukraine, Czech Rep. etc.), Rest of Europe
  • CIS & Russia
  • Japan
  • Asia Pacific Excluding Japan (Greater China, India, S. Korea, ASEAN Countries, Rest of APEJ)
  • Middle East and Africa (GCC Countries, Turkey, Iran, Israel, South Africa , Rest of MEA)

Get More Insights –http://www.globenewswire.com/en/news-release/2020/03/06/1996513/0/en/Fact-MR-Projects-Global-Sleep-Mask-Sales-to-Grow-at-4-CAGR-over-2019-2029-Wrap-around-Sleep-Masks-Emerging-Lucrative.html

The Report Covers Exhaustive Analysis On:

  • Market Segments
  • Market Dynamics
  • Market Size & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Rising Prevalence of Osteoporosis among Women Is Expected to Trigger the Demand for Estrogen Replacement Therapy

The Demand for hormone replacement therapy is foreseen to expand at a significant pace with sales of hormone replacement therapy products crossing US$ 12,000 Mn by 2019 end.

Rising incidences of osteoporosis fractures coupled with growing menopause rates among women have remained instrumental in driving the demand for hormone replacement therapy. Fact.MR envisages that the demand for hormone replacement therapy is projected to expand at a CAGR of 6.0% in terms of value throughout the period of forecast, 2018-2028.

For More Insights Into The Market, Request a Sample of this Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=2224

Disorders associated with hormonal imbalance continue to influence the use of hormone replacement therapy worldwide. Hormone replacement therapy demand is further pushed with macroeconomic aspects such as growing geriatric population and significant increase in healthcare expenditure worldwide. Growing age directly impacts secretion of hormones such as progesterone and estrogen in women, which is expected to trigger the use of estrogen hormone replacement therapy.

Expanding range of menopausal window (45-55 years) coupled with growing number of postmenopausal patients are few of the key factors influencing the growth of the hormone replacement therapy market.

Share Your Requirements & Get Customized Reports – https://www.factmr.com/connectus/sample?flag=RC&rep_id=2224

According to the report, the demand for estrogen hormone replacement therapy is expected to grow on the back of growing menopausal rate worldwide. The sales of estrogen hormone replacement therapy are likely to surpass US$ 18,000 Mn by 2028, higher than those of other hormone replacement therapy products including thyroid and growth hormone related hormone replacement therapy products, says the report.

Sales of hormone replacement therapy products through hospital pharmacies and retail pharmacies are likely to be on an upswing with developers of hormone replacement therapy products relying on these channels than online selling. Retail pharmacies are expected to remain an attractive distribution channel for hormone replacement therapy products, with sales accounting for a larger revenue share of the overall hormone replacement therapy market. The sales of hormone replacement therapy through clinics are projected to grow at a steady during the 2018-2028 timeline.

hormone replacement therapy market 0

Full Access of This Report Is Available At
https://www.factmr.com/checkout/2224

The hormone replacement therapy market is expected to remain influenced by increasing government support apropos to women’s health. Governments and non-profit organizations of various countries are spreading awareness regarding hormone replacement therapy along with providing free treatments to lower and middle class people. Regulatory authorities such as FDA are also contributing to the cause of supporting women’s health by launching initiatives such as Take Time To Care (TTTC) programs. This aspect is likely to support the growth of the hormone replacement therapy market in the coming years.

Sales of hormone replacement therapy products are likely to remain concentrated among developed countries of North America and Europe. Tug-of-war between North America and Europe apropos to demand for hormone replacement therapy has been witnessed since the past couple of years, with the latter gaining tempo over the former, says the report.

Stakeholders in the hormone replacement therapy can find attractive opportunities in developed countries in North America, particularly the United States. According to the American Congress of Obstetricians and Gynecologists, around 6,000 women reach menopause every day, reaching a count of over 2 million annually. This has translated into significant adoption of hormone replacement therapy in the country. The demand for hormone replacement therapy in the US is also accompanied by higher GDP per capita, triggering high healthcare expenditure.

For More Insights
https://www.biospace.com/article/increasing-kidney-disorder-prevalence-coupled-with-unhealthy-lifestyle-habits-are-driving-growth-of-global-bartter-syndrome-treatment-market

The report also foresees that the hormone replacement therapy market in Asia Pacific excluding Japan (APEJ) region is poised to expand at a relatively higher pace as compared to other regions. According to the report, the APEJ hormone replacement therapy market is projected to expand at a stellar pace of 7.2% during the assessment period. This growth can be attributed to increasing population coupled with higher life expectancy in emerging economies such as India and China. Against this backdrop, stakeholders in hormone replacement therapy market can expect optimistic growth in the region in the years to follow, leveraging its lucrativeness from an investment standpoint.

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

 

Categories
Pharmaceutical

Demand for Powered ENT Surgical System Devices Is Projected to Grow at 6.4% CAGR through 2028

ENT surgical devices market is expected to surpass US$ 2,500 million in 2019, according to a new study by Fact.MR. The ENT surgical devices market witnessed a steady progress and grew at 6.6% y-o-y in 2018. Overall growth of the ENT surgical devices market can be attributed to,

  • Technological advancements enhancing ENT procedure efficiency and outcome
  • Reimbursement policies in favor of ENT surgeries
  • Product developments accommodating demand trend such as minimal invasion

The medical technology industry has shifted from a traditional marketing model to a care delivery model. Following the new business approach, Tier 1 and Tier 2 players portray hegemony in the market and continue to introduce disruptive technology innovations in ENT surgical devices.

Click Here To get a Sample Report (Including Full TOC, Table & Figures):-
https://www.factmr.com/connectus/sample?flag=S&rep_id=2454

The study analyzes crucial trends that are currently determining market growth. This report explicates on vital dynamics, such as the drivers, restraints, and opportunities for key market players along with key stakeholders and emerging players associated with Dual Interface ENT Surgical Devices Market. The study also provides the dynamics that are responsible for influencing the future status of the market over the forecast period.

Key Segments Covered

  • Product Type
    • ENT Surgical Laser Devices
    • ENT Surgical Hand Instruments
    • Powered ENT Surgical System Devices
    • Radiofrequency ENT Electrosurgical Devices
    • ENT Surgery Workstations
    • ENT Surgical Navigation Systems
    • ENT Visualization Systems
    • ENT Surgical Microscopes
  • End User
    • ENT Surgical Devices for Hospitals
    • ENT Surgical Devices for Ambulatory Surgical Centers
    • ENT Surgical Devices for ENT Clinics
  • Modality
    • Hand-held ENT Surgical Devices
    • Portable ENT Surgical Devices
    • Fixed ENT Surgical Devices

Connect To an Expert:-https://www.factmr.com/connectus/sample?flag=AE&rep_id=2454

The Report Covers Exhaustive Analysis On:

  • Market Segments
  • Market Dynamics
  • Market Size & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

To Get All-In Insights On the Regional Landscape of The Report Market, Buy Now:-  https://www.factmr.com/checkout/2454

Fixed ENT Surgical Devices to Hold Over 37% Revenue Share in 2019

Based on modality, three types of devices are present – handheld, portable and fixed. Owing to the popularity of fixed devices, Fact.MR estimates that these devices will continue to account for a higher market share. On the other hand, handheld devices are estimated to account for the second largest revenue in the ENT surgical devices market and will register faster expansion in the coming years.

According to the study, North America dominates the ENT surgical devices market and will account for over one forth revenue share in 2019. The market growth in North America is favored by favorable healthcare reimbursement coverage. In addition, presence of industry leaders in the regions contributes to the higher market revenues.

The study finds that Europe follows North America with the second largest revenues. Europe and APEJ collectively held over half the revenues in 2018. While Europe presents an established market, improving healthcare infrastructure and economic standards in APEJ can be attributed to the growth scenario of the ENT surgical devices market in the coming years.

Some important questions that the ENT Surgical Devices Market report tries to answer exhaustively are: 

  • Key strategic moves by various players in the ENT Surgical Devices Market in recent years with respect to product launches, deals and tie-ups, and mergers and acquisitions, and divestment of shares
  • Which strategies will enable top players in the ENT Surgical Devices Market to expand their geographic footprints
  • Which new business models are expected to change the course of growth of key regional markets in near future
  • Which technologies will witness most attractive research investments and what will be the key sources of funding for startups and new entrants
  • Which products segments have in recent years have seen new, lucrative application areas

Need More Information about Report Methodology? Click here:-https://www.factmr.com/connectus/sample?flag=RM&rep_id=2454

The research attempts to answer many queries such as:

  1. What needs are the leading manufacturers trying to meet by the forecast period 2025?
  2. What challenges will vendors running the ENT Surgical Devices market go through?
  3. What aspects do the consumers look up while buying ENT Surgical Devices?
  4. How will the competitive framework look like between the foreseeable period 2018 to 2025?
  5. At present, who is buying your product or service globally?
  6. Who are your primary contenders?
  7. What will be the cost of the products and facilities across various regions?
  8. What are the trends affecting the performance of the ENT Surgical Devices market?

Read More Trending Reports of Fact.MR: –http://www.globenewswire.com/en/news-release/2018/04/30/1489775/0/en/6-Key-Takeaways-from-Fact-MR-s-Report-on-Drip-Coffee-Machine-Market-for-Forecast-Period-2017-2026.html

Benefits of Fact.MR Study

Fact.MR has gradually established itself as one of the leading market research companies across the globe. Our unique, methodical, and up-to-date approach towards creating high-quality market reports ensures the reports include relevant market insights. Further, our team of analysts leaves no stone unturned while curating market reports in accord with the requirement of our clients.

Explore Fact.MR’s Comprehensive Coverage on Healthcare Landscape

Minimally Invasive Surgery Market, Forecast, Trend, Analysis & Competition Tracking – Global Market Insights 2021 to 2031

Sterile Vials Market, Forecast, Trend, Analysis & Competition Tracking – Global Market Insights 2021 to 2031

Radiation Proctitis Treatment Market, Forecast, Trend, Analysis & Competition Tracking – Global Market Insights 2021 to 2031

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Demand for Lung Cancer Diagnostics CA Test Is Expected to Reach US$ 889.3 Mn by the End of 2022

Impact of Covid-19 on Healthcare Industry

With the pandemic plaguing maximum countries across the globe, healthcare industry is witnessing its fair share of ‘ups and downs’. The COVID-19 has placed an enormous strain on the healthcare sector’s workforce, facilities and infrastructure. Despite the endless pressure, healthcare sector is growing at a moderate pace due to the improvement in infrastructure and advancement in technology, healthcare sector is delivering a healthy performance.

According to a recent report by Fact.MR, the global demand for lung cancer diagnostics is anticipated to register 7.3% CAGR throughout the forecast period 2017 to 2022.

Growth of the global lung cancer diagnostics market is mainly attributed to surging developments in the lung cancer-specific biomarkers. Diagnostic tools, such as these, will facilitate personalized treatment approach for lung malignancies.

For More Insights Into The Market, Request a Sample of this Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=49

Numerous biomarkers are in the research pipeline. Epigenomics AG has launched a new test which is based on blood by utilizing DNA methylation biomarkers, and their developments are in process. Initial results of these tests have guaranteed early diagnosis of lung cancer. These incidences are most likely to increase demand for diagnosis of lung cancer across the globe.

10 Key Takeaways from Fact.MR’s Report on the Global Lung Cancer Diagnostics Market

  1. North America is expected to remain dominant in the global lung cancer diagnostics market, with revenues expected to surpass US$ 1,000 Mn by 2022-end.
  2. Europe will continue to be the second most lucrative region for growth of the market, expanding at a high single-digit CAGR through 2022.
  3. CA tests will remain the largest adopted tests for diagnosis of lung cancer. Revenue from CA tests is expected to reach US$ 889.3 Mn by the end of 2022.
  4. Angiogenesis inhibitor tests will exhibit the fastest expansion in the global market for lung cancer diagnostics, followed by HER 2 tests. However, revenue from ALK tests to diagnose lung cancer is estimated to be low in the market throughout the forecast period.
  5. Hospital-associated labs are expected to remain the most lucrative among end-users in the global lung cancer diagnostics market.
  6. Cancer research institutes are expected to register the fastest growth in the global market for lung cancer diagnostics.
  7. Independent diagnostic laboratories are expected to be the second largest end-users of lung cancer diagnostics throughout the forecast period.
  8. Based on indication, even though non-small cell lung cancer will remain sought-after, small cell-lung cancer will exhibit the fastest growth through 2022. Non-small cell lung cancer will continue to account for the largest revenues during the forecast period.
  9. Revenue from small cell lung cancer will continue to be low in the global lung cancer diagnostics market.

Fact.MR’s report profiles key market players, which include

Illumina, Inc.
Abbott Laboratories
Thermo Fischer Scientific Inc.
QIAGEN N.V.
Quest Diagnostics Incorporated
NeoGenomics Laboratories, Inc.
NanoString Technologies, Inc.
Myriad Genetics, Inc.
Roche Holding AG
Danaher Corporation.

Share Your Requirements & Get Customized Reports – https://www.factmr.com/connectus/sample?flag=RC&rep_id=49

Global Lung Cancer Diagnostics Market: Segmentation

For clearer understanding of the Lung Cancer Diagnostics Market, analysts have segmented the market. The segmentation has been done on the basis of application, technology, and users. Each segment has been further explained with the help of graphs figures. This breakdown of the market gives the readers an objective view of the global Lung Cancer Diagnostics Market, which is essential to make sound investments.

Market Taxonomy

Test Type End User Indication
CA Test Hospital Associated Labs Non Small-cell Lung Cancer
HER2 Tests Independent Diagnostic Laboratories Small-cell Lung Cancer
ALK Tests Cancer Research Institutes
Angiogenesis Inhibitor Others
EGFR Mutation Tests
KRAS Mutation Tests
Others

A market research study is incomplete without regional analysis, and we are well aware of it. That is why, the report includes a comprehensive and all-inclusive study that solely concentrates on the geographical growth of the global Lung Cancer Diagnostics Market. The study also includes accurate estimations about market growth at the global, regional, and country levels. It empowers you to understand why some regional markets are flourishing while others are seeing a decline in growth. It also allows you to focus on geographies that hold the potential to create lucrative prospects in the near future.

Segmentation:

Test Type

  • CA Test for Lung Cancer Diagnostics
  • HER2 Tests for Lung Cancer Diagnostics
  • ALK Tests for Lung Cancer Diagnostics
  • Angiogenesis Inhibitor for Lung Cancer Diagnostics
  • EGFR Mutation Tests for Lung Cancer Diagnostics
  • KRAS Mutation Tests for Lung Cancer Diagnostics
  • Others

End-User

  • Lung Cancer Diagnostics  for Hospital Associated Labs
  • Lung Cancer Diagnostics for Independent Diagnostic Laboratories
  • Lung Cancer Diagnostics for Cancer Research Institutes
  • Others

Indication

  • Non-Small-cell Lung Cancer Diagnostics
  • Small-cell Lung Cancer Diagnostics

Following Questions Answers Covered in the Report are:

  • How will the global Lung Cancer Diagnostics Market perform during the forecast period? What will be the market size in terms of value and volume?
  • Which segment will drive the global Lung Cancer Diagnostics Market? Which regional market will show extensive growth in the future? What are the reasons?
  • How will the market dynamics change because of the impact of future market opportunities, restraints, and drivers?
  • What are the key strategies adopted by players to sustain themselves in the global Lung Cancer Diagnostics Market?
  • How will these strategies influence the market growth and competition?

Access Research Methodology Prepared By Experts – https://www.factmr.com/connectus/sample?flag=RM&rep_id=49

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Brazil, Mexico, Argentina, Chile, Peru, Rest of LATAM)
  • EU – (Germany, France, Italy, Spain), UK, BENELUX (Belgium, Netherlands, Luxemburg), NORDIC (Norway, Denmark, Iceland, Sweden), Eastern Europe (Poland, Ukraine, Czech Rep. etc.), Rest of Europe
  • CIS & Russia
  • Japan
  • Asia Pacific Excluding Japan (Greater China, India, S. Korea, ASEAN Countries, Rest of APEJ)
  • Middle East and Africa (GCC Countries, Turkey, Iran, Israel, South Africa , Rest of MEA)

 

Get More Insights –http://www.globenewswire.com/en/news-release/2020/03/17/2001947/0/en/Sales-of-Automotive-Wrap-Films-to-Expand-6X-Between-2019-and-2029-MEA-Poised-to-Turn-Highly-Lucrative-Forecasts-a-New-Fact-MR-Report.html

 

The Report Covers Exhaustive Analysis On:

  • Market Segments
  • Market Dynamics
  • Market Size & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

The Lung Cancer Diagnostics Market report answers the following queries:

  1. What is the largest share held by key players in the market?
  2. What strategies have proven most advantageous in the Lung Cancer Diagnostics Market?
  3. Which region promises largest opportunity for new investors during the forecast period 2021 to 2031?
  4. What factors will most likely present challenges to growth during the forecast period?
  5. What will be the value of total revenues, and at what CAGR will the growth compound during the forecast period 2021 to 2031?

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Growing Demand from Blood Banks and Transfusion Centers to Boost Sales of Tissue Blood Thawing Systems: Fact.MR

Big data and analytics will drive patient outcomes in a big way, and the coming years will witness a growing emphasis on healthcare service providers in the business of gathering and processing patient health data.

Sales of blood thawing systems are gaining momentum as the requirement for 2-bag, 4-bags, and dry plasma thawers has been increasing. With rising demand from blood banks, transfusion centers, hospitals, and diagnostic laboratories, blood thawing system manufacturers are expected to come across significant growth scope over the coming years.

A new report by Fact.MR offers an exhaustive overview of global industry trends, demand-supply patterns, and other crucial factors related to blood thawing systems during the forecast period of 2021 to 2031. According to the report, leading players are eyeing the regional markets of North America and Europe, while Asia Pacific will also emerge as another highly lucrative market for blood thawing systems over the coming years.

For detailed insights on enhancing your product footprint, request for a sample here- 

https://www.factmr.com/connectus/sample?flag=S&rep_id=5772

Key Takeaways from Market Study

  • High demand for dry plasma thawers likely to be witnessed
  • Blood plasma and RBCs to emerge as leading segments in terms of sample
  • Growing demand from blood banks and transfusion centers to boost sales of blood thawing systems
  • The United States to hold major share of the North American market for blood thawing systems
  • Germany to remain the hotspot in Europe for blood thawing systems
  • China remains the epicenter of the world’s fastest-growing market for blood thawing systems – Asia Pacific
  • India, Japan, the United Kingdom, France, Italy, and Canada to maintain positive industry outlook throughout the forecast period

Market Segmentation

Fact.MR’s research study assesses the global blood thawing system market in terms of product type, capacity, sample, end user, and region. This report presents extensive market dynamics and trends associated with different segments of the market, and their influence on the growth prospects of the market.

Need more information about Report Methodology? Click here- https://www.factmr.com/connectus/sample?flag=RM&rep_id=5772

Product Type
  • Dry Plasma Thawers
  • Wet Plasma Thawers
Capacity
  • 2 Bags
  • 4 Bags
  • 8 Bags
  • Others
Sample
  • Blood Plasma
  • RBCs
  • Platelets
  • Whole Blood
  • Others
End User
  • Blood Banks
  • Transfusion Centers
  • Hospitals & Diagnostic Laboratories
  • Pharmaceutical Companies
  • Others
Region
  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East & Africa (MEA)

Key Questions Answered in Report

For comprehensive insights on this market adoption, ask an analyst here- 

https://www.factmr.com/connectus/sample?flag=AE&rep_id=5772

  • Which are the most lucrative markets for blood thawing systems?
  • Which factors will impact the demand for blood thawing systems?
  • How will changing trends impact the strategies of market players?
  • How can market players capture the low-hanging opportunities across regions?
  • Which companies are leading the global blood thawing system market?
  • What are the winning strategies of stakeholders in the blood thawing system landscape?

blood thawing system market

Inspected Assessment on Regional Segments

Key sections have been elaborated in the report, which have helped deliver projections on regional markets. These chapters include regional macros (political, economic, and business environment outlook), which are expected to have a momentous influence on the growth of the market during the forecast period.

Country-specific valuation on demand for blood thawing systems has been offered for each regional market, along with market scope estimates and forecasts, price index, and impact analysis of the dynamics of prominence in regions and countries. For all regional markets, Y-o-Y growth estimates have also been incorporated in the report.

Detailed breakup in terms of value for emerging countries has also been included in the report.

For in-depth competitive analysis, buy now- https://www.factmr.com/checkout/5772

Key Competitve Players

  • Fremon Scientific Inc.
  • Helmer Scientific Inc.
  • Barkey GmbH & Co. KG
  • Boekel Scientific
  • KW Scientific Apparatus Srl
  • Cardinal Health
  • Cytiva
  • Sarstedt AG & Co. KG
  • Thermo Fisher Scientific, Inc.
  • Sartorius AG

For More Insights: 

https://www.biospace.com/article/andersen-tawil-syndrome-market-gains-ground-with-government-incentives-towards-rare-disease-treatments-fact-mr/

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com